Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prospex Medical was a medical technology company that developed embolic protection devices for use during vascular procedures. Its primary innovation was a filter-based system designed to capture and remove debris, such as plaque, that might be dislodged during carotid artery stenting. By capturing these particles, the device aimed to prevent embolic strokes, which are a significant risk during such interventions. The company was founded by Dr. Thomas Fogarty, a prolific inventor in the field of cardiovascular medicine. In 2001, Boston Scientific acquired Prospex Medical to enhance its portfolio of peripheral vascular intervention tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prospex Medical.